# Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening

> **NCT06549725** · NA · RECRUITING · sponsor: **Lipidica, a.s.** · enrollment: 419 (estimated)

## Conditions studied

- Pancreas Cancer
- Pancreatic Ductal Adenocarcinoma
- Hereditary Diseases
- Pancreatitis, Chronic

## Interventions

- **DEVICE:** software Lipidica
- **PROCEDURE:** endoscopic ultrasonography
- **PROCEDURE:** magnetic resonance
- **DIAGNOSTIC_TEST:** laboratory examination
- **PROCEDURE:** computed tomography

## Key facts

- **NCT ID:** NCT06549725
- **Lead sponsor:** Lipidica, a.s.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-10
- **Primary completion:** 2027-09-26
- **Final completion:** 2027-09-26
- **Target enrollment:** 419 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06549725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06549725, "Clinical Performance of Medical Device Software "Lipidica 1.0" for Processing Data Generated by Lipidomic Analysis in Pancreatic Cancer Screening". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06549725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*